BriaCell Therapeutics Corp.
Balance Sheet
| Line Item | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $6.9M | $29.9M | $2.7M | $10.5M | $12.5M | $5.0M | $5.8M | $862.1K |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $25.4M | $32.2M | $11.3M | $19.9M | $14.8M | $7.2M | $8.2M | $3.7M |
| Property, Plant & Equipment | $349.0K | $251.1K | $274.0K | $296.8K | $319.7K | $342.5K | $365.3K | $388.2K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $180.7K | $184.5K | $188.3K | $192.2K | $196.0K | $199.8K |
| Total Assets | $27.1M | $33.6M | $13.1M | $21.6M | $17.0M | $9.4M | $10.4M | $5.9M |
| Liabilities | ||||||||
| Accounts Payable | $2.2M | $1.9M | $2.1M | $3.3M | $3.3M | $5.0M | $4.2M | $7.2M |
| Total Current Liabilities | $3.6M | $3.2M | $3.3M | $4.0M | $4.3M | $5.2M | $5.0M | $7.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $3.7M | $3.4M | $3.7M | $4.3M | $5.1M | $6.1M | $6.7M | $8.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-134.3M | $-127.2M | $-120.0M | $-111.8M | $-103.7M | $-97.5M | $-91.2M | $-85.4M |
| Total Stockholders' Equity | $23.4M | $30.2M | $9.4M | $17.3M | $11.9M | $3.2M | $3.7M | $-2.7M |